Browse By Region
Browse By Category
Recent News
By Category: Biotechnology
New Jersey Firm Wins $8.2M Biodefense Contract
The New Jersey biopharmaceutical firm Snowdon on Tuesday announced receiving a three-year Defense Department contract worth up to $8.2 million for the creation of biological warfare countermeasures (see GSN, Sept. 21). Experimental drugs developed for fighting particular disease agents would undergo testing in secured facilities at the Center for Emerging and Re-emerging Pathogens in New Read More »
- November 11, 2010
- | Filed under North America, Biotechnology, Countermeasures, and Research
U.S. Awards Contract For Biodefense Diagnostic Technology
Defense contractor Northrop Grumman said Friday it has received nearly $10 million from the U.S. Health and Human Services Department to produce a diagnostic system that could quickly verify whether an individual has been contaminated by a dangerous pathogen (see GSN, June 16). The one-year, $9.6-million deals calls for preparation, production and assessment of two Read More »
- November 10, 2010
- | Filed under North America and Biotechnology
Synthetic DNA makers alerted to bioterrorism threats
Scientists have been engineering genetic sequences for decades and commercial gene sequencing has been around for years — but this year, researchers for the first time were able to design and produce cells that do not exist in nature without using pre-existing biological matter — marking the latest evolution in the rapidly advancing field of Read More »
- October 28, 2010
- | Filed under Biotechnology
U.S. to Award Smallpox Treatment Contract
The U.S. Health and Human Services Department is set to award SIGA Technologies a contract worth up to $2.8 billion to prepare at least 1.7 million courses of smallpox treatment for the Strategic National Stockpile of medical countermeasures, the Associated Press reported yesterday (see GSN, Oct. 8). Completion of the deal hinges on a competing Read More »
- October 14, 2010
- | Filed under North America, Biotechnology, and Public Health
NIH Funds Advanced Development of 3 Biodefense Vaccines
NIH funds advanced development of 3 biodefense vaccinesWebnewswire.com (press release)… says Michael G. Kurilla, MD, Ph.D., director of the Office of Biodefense Research Affairs in NIAIDs Division of Microbiology and Infectious Diseases. …
- October 10, 2010
- | Filed under North America, Biotechnology, Countermeasures, and Public Health